Analyst	Recommendation	Action	Price target	Projected	Date
Damon Delmonte KBW	Buy	Maintained	$14.50	+30%	11/01/2026
Manuel Navas Piper Sandler	Buy	Maintained	$14.00	+25.6%	10/30/2026
Daniel Cardenas Brean Capital	Buy	Upgraded	$14.00	+25.6%	08/17/2026

All values in USD	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	66.70M	66.18M	69.44M	72.95M
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	46.10M	44.59M	46.60M	61.16M
Operating expense	45.44M	44.08M	46.77M	62.80M
Total operating expenses	45.44M	44.08M	46.77M	62.80M
Operating income	21.26M	22.10M	22.66M	10.15M
Other non operating income	-1.40M	-1.58M	-1.83M	-2.33M
EBT including unusual items	19.65M	18.70M	20.02M	1.14M
EBT excluding unusual items	19.86M	20.52M	20.84M	7.82M
Income tax expense	3.95M	5.60M	5.53M	-4.10M
Effective tax rate	20.12%	29.93%	27.64%	-360.48%
Other operating expenses	-660.00K	-509.00K	169.00K	1.64M
Net income	15.69M	13.10M	14.49M	5.23M
Net profit margin	23.53%	19.79%	20.86%	7.17%
Earnings per share	0.07	0.07	0.07	0.17
Interest and investment income	-	-	-	-
Interest expense	-	-	-	-
Net interest expenses	-	-	-	-
Depreciation and amortization charges	-	-	-	-
EBITDA	-	-	-	-
Gain or loss from assets sale	-24.00K	-20.00K	-755.00K	-

Ask anything